Trustworthy development and commercial manufacturing of CELL&GENE therapies.
LET’S ACCELERATE YOUR JOURNEY FROM BENCH TO BEDSIDE
CELLforCURE by SEQENS stands as a leading EMA-authorized CDMO, dedicated to advancing Cell & Gene Therapies from concept to commercialization.
CELLforCURE by SEQENS quality systems are continuously reviewed to follow international recognized quality standards, including those of U.S. regulatory agencies.
With advanced technologies, extensive capabilities, and large scale capacity, we offer a seamless journey from early-stage development to commercial manufacturing of a wide range of cell therapies within our fully integrated “One Stop Shop” facility.
We design our GMP manufacturing lines around your process
At CELLforCURE by SEQENS, we offer on-demand GMP manufacturing lines precisely tailored to your process and product needs, from Phase I trials to full commercial production.
Our dedicated team of experts brings deep knowledge and expertise to every project, allowing you to leverage our experience and technical know-how for success at every stage.
Our dedicated team of experts brings deep knowledge and expertise to every project, allowing you to leverage our experience and technical know-how for success at every stage.
- 6 ATMP GMP MANUFACTURING LINES
Modular, Flexible and Forward design - ALL IN ONE SOLUTION FROM CONCEPT TO COMMERCIAL PRODUCTION
Process and Analytical Development, Tech Transfer, Quality Control, GMP Manufacturing and Product Release - SUPPLY CHAIN MANAGEMENT
Central EU Commercial Manufacturing Facility - DEEP EXPERTISE AND ON-DEMAND SUPPORT
10 years of CDMO and commercial production of autologous batches - PROJECT MANAGEMENT
From technology transfer to manufacturing, covering all phases from Phase I to commercial production. - QUALITY CONTROL
Quality Control Support & Testing for in-process controls, batch release and stability studies
Key Figures
1
All in one site – Central EU From technology transfer to commercial manufacturing
+130
Employees
+10 years
As CDMO and commercial production
300 sqm
Development area : Technology Transfer – Development – Industrialization
+ 2,200 sqm GMP Production area
High capacity From Phase I to commercial
6 Independent GMP Manufacturing Lines
Flexible, modular and monitored